Spironolactone and Breast Cancer: No evidence of Increased Risk
I just posted a new answer to our “Question of the Week.” I was asked to outline what is known at present about the risk of developing breast cancer in women who use spironolactone. Fortunately, there is no evidence that spironolactone use increases the risk of developing breast cancer.
The full answer to this week’s question can be read here:
To submit a new question for consideration of our Question of the Week, simply visit complete our online form
Dr. Jeff Donovan is a Canadian and US board certified dermatologist specializing exclusively in hair loss. To schedule a consultation, please call the Whistler office at 604.283.1887